Comparison of YEARS and Adjust-Unlikely D-dimer Testing for Pulmonary Embolism in the Emergency Department.


Journal

Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646

Informations de publication

Date de publication:
05 2023
Historique:
received: 06 06 2022
revised: 05 09 2022
accepted: 19 09 2022
medline: 25 4 2023
pubmed: 13 11 2022
entrez: 12 11 2022
Statut: ppublish

Résumé

We prospectively assessed the diagnostic accuracy of YEARS and a modified age-adjusted clinical decision rule ("Adjust-Unlikely") for pulmonary embolism (PE) testing in the emergency department. This study was conducted in tertiary care Canadian emergency departments. When the D-dimer was <500 ng/ml, PE was excluded. Pulmonary imaging for PE was performed when the D-dimer was ≥500 ng/ml. Patients were followed for 30 days, and PE outcomes were independently adjudicated. Physicians systematically recorded the presence or absence of YEARS items (PE most likely, hemoptysis, signs of deep venous thrombosis) prior to D-dimer testing and imaging. We analyzed the diagnostic accuracy of YEARS and the "Adjust-Unlikely" rule. Age adjustment (age x 10 in those >50 years old) was applied in patients where PE was not the most likely diagnosis and 500 ng/ml threshold when PE was most likely. One thousand seven hundred three patients were included, median age 62 (50, 74), 58% female, PE prevalence 8.0%. YEARS sensitivity for PE diagnosis was 92.6% (87.0, 96.0%) and specificity 45.0% (42.5, 47.5%). Adjust-Unlikely sensitivity was 100.0% (97.2, 100.0%) and specificity 32.4% (30.1, 34.8%). Posttest probability of PE in the group of patients with PE excluded by D-dimer between 500 ng/ml and the adjusted limit was 2.8% (1.6, 5.1%) for YEARS and 0.0% (0.0, 2.6%) for the "Adjust-Unlikely" rule. The "Adjust-Unlikely" rule would modestly reduce imaging and identify all cases of PE. YEARS would substantially reduce imaging but miss 1 in 14 cases of PE.

Identifiants

pubmed: 36371248
pii: S0196-0644(22)01118-0
doi: 10.1016/j.annemergmed.2022.09.014
pii:
doi:

Substances chimiques

fibrin fragment D 0
Fibrin Fibrinogen Degradation Products 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-565

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Kerstin de Wit (K)

Department of Emergency Medicine and Medicine, Queens University, Kingston, and Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. Electronic address: kerstin.deWit@queensu.ca.

Fayad Al-Haimus (F)

Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Yang Hu (Y)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Rick Ikesaka (R)

Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Noel Chan (N)

Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Quazi Ibrahim (Q)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Joshua Klyn (J)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Natasha Clayton (N)

Department of Medicine, McMaster University, Hamilton, ON, Canada; Emergency Department, Hamilton Health Sciences, Hamilton, ON, Canada.

Federico Germini (F)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH